Literature DB >> 21166956

Leptin receptor is involved in STAT3 activation in human colorectal adenoma.

Takashi Uchiyama1, Hirokazu Takahashi, Michiko Sugiyama, Eiji Sakai, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Masato Yoneda, Masahiko Inamori, Yoji Nagashima, Yoshiaki Inayama, Koichiro Wada, Atsushi Nakajima.   

Abstract

The possible role of leptin in colorectal tumors has been investigated in previous studies; however, to date, the conclusions remain under debate. Therefore, we investigated the serum leptin levels in colorectal adenoma patients. In addition, expression of the leptin receptor, and the leptin receptor-mediated signaling pathways were investigated in biopsy specimens collected from human patients with colorectal adenoma. No significant difference in the mean serum leptin level was observed between the colorectal adenoma patients and the control subjects; however, increased expression and activation of the leptin receptor, as indicated by findings such as the phosphorylation of Tyr 1141, was observed in the colorectal adenoma tissues. In addition, activation of the JAK/STAT signaling pathway mediated by the leptin receptor and increased transcriptional regulation of downstream target molecules were observed in colorectal adenomas compared with the non-adenoma tissues. These results indicate STAT3-mediated leptin receptor signaling pathways may be activated in human colorectal adenomas.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166956     DOI: 10.1111/j.1349-7006.2010.01803.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.

Authors:  Wenzhong Liu; Rajvir Singh; Cheol Soo Choi; Hui-Young Lee; Ali R Keramati; Varman T Samuel; Richard P Lifton; Gerald I Shulman; Arya Mani
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

Review 2.  Obesity and cancer: inflammation bridges the two.

Authors:  Ryan Kolb; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Curr Opin Pharmacol       Date:  2016-07-16       Impact factor: 5.547

Review 3.  Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?

Authors:  Katie E O'Sullivan; John V Reynolds; Ciara O'Hanlon; Jacintha N O'Sullivan; Joanne Lysaght
Journal:  J Gastrointest Cancer       Date:  2014-03

Review 4.  Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis.

Authors:  Xiaoqian Zhang; Shanglong Liu; Yanbing Zhou
Journal:  Oncotarget       Date:  2016-09-27

5.  Adiponectin, Leptin, IGF-1, and Tumor Necrosis Factor Alpha As Potential Serum Biomarkers for Non-Invasive Diagnosis of Colorectal Adenoma in African Americans.

Authors:  Hassan Ashktorab; Akbar Soleimani; Alexandra Nichols; Komal Sodhi; Adeyinka O Laiyemo; Gail Nunlee-Bland; Seyed Mehdi Nouraie; Hassan Brim
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-12       Impact factor: 5.555

6.  Sex differences in associations among metabolic syndrome, obesity, related biomarkers, and colorectal adenomatous polyp risk in a Japanese population.

Authors:  Keisuke Nakai; Jiro Watari; Katsuyuki Tozawa; Akio Tamura; Ken Hara; Takahisa Yamasaki; Takashi Kondo; Tomoaki Kono; Toshihiko Tomita; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jun Sakurai; Yongmin Kim; Yuji Hayakawa; Takashi Fujisawa; Takeshi Morimoto; Hiroto Miwa
Journal:  J Clin Biochem Nutr       Date:  2018-04-03       Impact factor: 3.114

7.  Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.

Authors:  Li Jiang; Xu-Hai Zhao; Yin-Ling Mao; Jun-Feng Wang; Hui-Jun Zheng; Qing-Shan You
Journal:  J Exp Clin Cancer Res       Date:  2019-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.